Machine Learning & AI for Prostate Cancer Data

This subcontract involves designing and implementing machine learning and artificial intelligence models focused on clinical and molecular data related to prostate cancer. The main objectives include predicting risk levels, distinguishing tumor subtypes, and forecasting responses to various treatments. The work aims to leverage advanced computational techniques to improve understanding and management of prostate cancer through data-driven insights. The contract is issued by the Department of the Army under the Department of Defense and has a solicitation posted on May 21, 2026. Responses are due by September 2, 2026. It falls under the NAICS code 541721, which covers research and development in the physical, engineering, and life sciences. While specific details about the location of work or organization type are not provided, the focus is clearly on applying innovative AI methodologies to critical biomedical data for enhanced clinical outcomes in prostate cancer care.